T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californca acetylcholine receptor α chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products

Autoimmunity

Volumn 27, Issue 2, 1998, Pages 79-90

  Oshima, Minako ^a   Yokoi, Tsuyoshi ^a,b   Deitiker, Philip ^a   Atassi, M Zouhair ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Acetylcholine receptor; Immunogenicity; Myasthenia gravis; Synthetic peptides; T cells

Indexed keywords

CHOLINERGIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; FEMALE; IMMUNIZATION; MALE; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; T LYMPHOCYTE; TORPEDO;

EID: 0031977368     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939809008038     Document Type: Article

References (52)

1. Appel, S. H., Almon, R. R. and Levy, N. (1975). Acetylcholine receptor antibodies in myasthenia gravis. N. Engl. J. Med., 293, 760-761.
2. Lindstrom, J. M., Seybold, M. E., Lennon, V. A., Whittingham, S. and Duane, D. D. (1976). Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 26, 1054-1059.
3. Hohlfeld, R., Kalies, I., Kohleisen, B., Heininger, K., Conti-Tronconi, B. and Toyka, K. V. (1986). Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology. 36, 618-621.
4. Melms, A., Schalke, B. C. G., Kirchner, T., Muller-Hermelink, H. K., Albert, E. and Wekerle, H. (1988). Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J. Clin. Invest., 81, 902-908.
5. Harcourt, G. C., Sommer, N., Rothbard, J., Willcox, H. N. A. and Newsom-Davis, J. (1988). A juxtamembrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. J. Clin. Invest., 82, 1295-1300.
6. Oshima, M., Ashizawa, T., Pollack, M. S. and Atassi, M. Z. (1990). Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the α subunit. Eur. J. Immunol., 20, 2563-2569.
7. Ashizawa, T., Ruan, K.-H., Jinnai, K. and Atassi, M. Z. (1992). Profile of the regions on the α-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol. Immunol., 29, 1507-1514.
8. Karlin, A. (1980). Molecular properties of nicotinic acetylcholine receptors. In Cell Surface and Neuronal Function (Edited by Colman C. W., Poste G. and Nicolson G. L.), Elsevier/North-Holland Biomedical Press, New York, 191-260.
9. Changeux, J. P., Devillers-Thiery, A. and Chemouilli, P. (1984). Acetylcholine receptor: an allosteric protein in its membrane-bound and detergent-extracted forms from Torpedo marmorata electric organ. Eur. J. Biochem., 80, 215-224.
10. Santa, T., Engel, A. G. and Lambert, E. H. (1972). Histometric study of neuromuscular junction ultrastructure: I. Myasthenia gravis. Neurology, 22, 71-82.
11. Engel, A. G., Tsujihata, M., Lindstrom, J. M. and Lennon, V. A. (1976). The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. Ann. N. Y. Acad. Sci., 274, 60-79.
12. Pascuzzi, R. M. and Campa, J. F. (1988). Lymphorrhage localized to the muscle end-plate in myasthenia gravis. Arch. Pathol. Lab. Med., 112, 934-937.
13. Fambrough, D. M., Drachman, D. B. and Satyamurti, S. (1973). Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science, 182, 293-295.
14. Ito, Y., Miledi, R., Vincent, A. and Newsom-Davis, J. (1978). Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis. Brain, 101, 345-368.
15. Ashizawa, T. and Appel, S. H. (1985). Immunopathologic events at the endplate in myasthenia gravis. Springer Semin. Immunopathol., 8, 177-196.
16. Pachner, A. R. (1987). Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment. Yale J. biol. Med., 60, 169-177.
17. Kaul, R., Shenoy, M., Goluszko, E. and Christadoss, P. (1994). Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis. J. Immunol., 152, 3152-3157.
18. Krolick, K. A. and Urso, O. E. (1987). Analysis of helper-T-cell function by acetylcholine receptor-reactive cell lines of defined AChR-subunit specificity. Cell, Immunol., 105, 75-85.
19. Asthana, D., Fujii, Y., Huston, G. E. and Lindstrom, J. (1993). Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis is mediated by IL-4 and antigen-specific T cell factors. Clin. Immunol. Immunopathol., 67, 240-248.
20. Ofosu-Appiah, W., Mokhtarian, F., Shirazian, D. and Grob, D. (1994). Production of anti-acetylcholine receptorα antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes. J. Lab. Clin. Med., 124, 231-241.
21. Rosenberg, J. S., Oshima, M. and Atassi, M. Z. (1996). B-cell activation in vitro by helper T cells specific to region α146-162 of Torpedo californica nicotinic acetylcholine receptor. J. Immunol., 157, 3192-3199.
22. Oshima, M., Pachner, A. R. and Atassi, M. Z. (1994). Profile of the regions of acetylcholine receptor α chain recognized by T-lymphocytes and by antibodies in EAMG-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor. Mol. Immunol., 31, 833-843.
23. Infante, A. J., Thompson, P. A., Krolick, K. A. and Walt, K. A. (1991). Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes. J. Immunol., 146, 2977-2982.
24. + cells sensitized to nicotinic acetylcholine receptor. J. Immunol., 147, 1484-1491.
25. Shenoy, M., Oshima, M., Atassi, M. Z. and Christadoss, P. (1993). Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region α146-162 of acetylcholine receptor. Clin, Immunol. Immunopathol., 66, 230-238.
26. Shenoy, M., Goluszko, E. and Christadoss, P. (1994). The pathogenic role of acetylcholine receptor α chain epitope within α 146-162 in the development of experimental autoimmune myasthenia gravis in C57BL6 mice. Clin. Immunol. Immunopathol., 73, 338-343.
27. Atassi, M. Z., Yokota, S., Twining, S. S., Lehmann, H. and David, C. S. (1981). Genetic control of the immune response to myoglobin. VI. Inter-site influences in T-lymphocyte proliferative response from analysis of cross-reactions often myoglobins in terms of substitutions in the antigenic sites and in environmental residues of the sites. Mol. Immunol., 18, 945-948.
28. Mulac-Jericevic, B. and Atassi, M. Z. (1987).α-Neurotoxin binding to acetylcholine receptor: localization of the full profile of the cobratoxin-binding regions on the α-chain of Torpedo californica acetylcholine receptor by a comprehensive synthetic strategy. J. Prot. Chem., 6, 365-373.
29. Mulac-Jericevic, B., Kurisaki, J. and Atassi, M. Z. (1987). Profile of the continuous antigenic regions on the extracellular part of the α chain of an acetylcholine receptor. Proc. Natl. Acad. Sci. USA, 84, 3633-3637.
30. Yokoi, T., Mulac-Jericevic, B., Kurisaki, J. and Atassi, M. Z. (1987). T lymphocyte recognition of acetylcholine receptor: localization of the full T cell recognition profile on the extracellular part of the a chain of Torpedo californica acetylcholine receptor. Eur. J. Immunol., 17, 1697-1702.
31. BM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice. Scand. J. Immunol., 42, 215-225.
32. Pachner, A. R., Kantor. F. S., Mulac-Jericevic, B. and Atassi, M. Z. (1989). An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides. Immunol. Lett., 20, 199-204.
33. Lennon, V. A., McCormick, D. J., Lambert, E. H., Griesmann, G. E. and Atassi, M. Z. (1985). Region of peptide 125-147 of acetylcholine receptor α subunit is exposed at the neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies. Proc. Nait. Acad. Sci. USA, 82, 8805-8809.
34. Atassi, M. Z., Ruan, K.-H., Jinnai, K., Oshima, M. and Ashizawa, T. (1992). Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide. Proc. Natl. Acad. Sci. USA, 89, 5852-5856.
35. Vincent, A., Jacobson, L. and Shillito, P. (1994). Response to human acetylcholine receptor α138-199: determinant spreading initiates autoimmunity to self-antigen in rabbits. Immunol. Lett., 39, 269-275.
36. Bixler, G. S. and Atassi, M. Z. (1985). Antigen presentation of myoglobin: profiles of T cell proliferative responses following priming with synthetic overlapping peptides encompassing the entire molecule. Eur. J. Immunol., 15, 917-922.
37. Bixler, G. S., Yoshida, T. and Atassi, M. Z. (1985). Antigen presentation of lysozyme: T-cell recognition of peptide and intact protein after priming with synthetic overlapping peptides comprising the entire protein chain. Immunology, 56, 103-112.
38. Brett, S. J., Cease, K. B. and Berzofsky, J. A. (1988). Influences of antigen processing on the expression of the T cell repertoir. Evidence for MHC-specific hindering structures on the products of processing. J. exp. Med., 168, 357-373.
39. Sercarz, E. E., Lehmann, P. V., Ametani, A., Benichou, G., Miller, A. and Moudgil, K. (1993). Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol., 11, 729-766.
40. Salemi, S., Caporossi, A. P., Boffa, L., Longobardi, M. G. and Barnaba, V. (1995). HIV gp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J. exp. Med., 181, 2253-2257.
41. Matsuo, H., Batocchi, A.-P., Hawke, S., Nicolle, M., Jacobson, L., Vincent, A., Newsom-Davis, J. and Willcox, N. (1995). Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. J. Immunol., 155, 3683-3692.
42. Ong, B., Willcox, N., Wordsworth, P., Beeson, D., Vincent, A., Altman, D., Lanchbury, J. S. S., Harcourt, G. C., Bell, J. I. and Newsom-Davis, J. (1991). Critical role for the Val/Gly86 HLA-DRb dimorphism in autoantigen presentation to human T cells. Proc. Natl. Acad. Sci. USA, 88, 7343-7347.
43. Celada, F. and Sercarz, E. E. (1988). Preferential pairing of T-B specificities in the same antigen: the concept of directional help. Vaccine, 6, 94-98.
44. De Kroon, A. I. P. M. and McConnell, H. M. (1993). Enhancement of peptide antigen presentation by a second peptide. Proc. Natl. Acad. Sci. USA, 90, 8797-8801.
45. Feng, M-H. L, and Lai, M.-Z. (1994). A peptide binding weakly to the major histocompatibility molecule augments T cell responses. Eur. J. Immunol., 24, 355-361.
46. bm12. A new H-2 mutation in the I region in the mouse. J. exp. Med., 150, 1323-1338.
47. bm12 gene is evidence for genetic exchange between mouse immune response genes. Nature, 308, 551-553.
48. b on binding with and antigen presentation of Torpedo acetylcholine receptor α-chain peptide 146-162. J. Immunol., 154, 5245-5254.
49. Marsh, S. G. E. and Bodmer, J. G. (1995). HLA class II region nucleotide sequences, 1995. Tissue Antigens, 45, 258-280.
50. Parham, P. and Ohta, T. (1996). Population biology of antigen presentation by MHC class 1 molecules. Science, 272, 67-73.
51. Atassi, M. Z. and Mulac-Jericevic, B. (1994). Mapping the extracellular topography of the α-chain in free and in membrane-bound acetylcholine receptor by antibodies against overlapping peptides spanning the entire extracellular parts of the chain. J. Prot. Chem., 13, 37-47.
52. McCormick, D. J. and Atassi, M. Z. (1984). Localization and synthesis of the acetylcholine-binding site in the α-chain of the Torpedo californica acetylcholine receptor. Biochem. J., 224, 995-1000.